Han Chong Toh, Pei-Jer Chen, Brian I. Carr, Jennifer J. Knox, Sharlene Gill, Peter Ansell, Evelyn M. McKeegan, Barry Dowell, Michelle Pedersen, Qin Qin, Jiang Qian, Frank A. Scappaticci, Justin L. Ricker, Dawn M. Carlson and Wei Peng Yong Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma Cancer 119
Article first published online: 25 JUL 2012 | DOI: 10.1002/cncr.27758
In this multicenter international phase 2 trial, the compelling clinical activity of linifanib was demonstrated in patients with advanced hepatocellular carcinoma (HCC). Further evaluation in patients with advanced HCC is ongoing.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.